Difference between revisions of "Part:BBa K4375006"
Line 3: | Line 3: | ||
<partinfo>BBa_K4375006 short</partinfo> | <partinfo>BBa_K4375006 short</partinfo> | ||
− | CEA-specific (carcinoembryonic antigen) Nanobody is | + | CEA-specific (carcinoembryonic antigen) Nanobody is optimized for production in E. coli. |
− | + | ==Usage and Biology== | |
− | + | ||
+ | The human carcinoembryonic antigen (CEA) is a well-studied tumor biomarkers in pancreatic cancer and is overexpressed in 83–98% of pancreatic cancers. CEA is a cell-surface glycoprotein that is normally expressed during embryogenesis, with little to no expression in normal tissue, and is used as a serum tumor marker in patients with pancreatic cancer. The Anti-CEA Nanobody recognises this tumour marker. For this reason, it is often used in a labelled form to identify tumours. | ||
<!-- --> | <!-- --> | ||
<span class='h3bb'>Sequence and Features</span> | <span class='h3bb'>Sequence and Features</span> | ||
<partinfo>BBa_K4375006 SequenceAndFeatures</partinfo> | <partinfo>BBa_K4375006 SequenceAndFeatures</partinfo> | ||
+ | |||
+ | ==References== | ||
+ | |||
+ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138244/ | ||
Revision as of 09:10, 7 October 2022
Anti-CEA Nanobody (C43)
CEA-specific (carcinoembryonic antigen) Nanobody is optimized for production in E. coli.
Usage and Biology
The human carcinoembryonic antigen (CEA) is a well-studied tumor biomarkers in pancreatic cancer and is overexpressed in 83–98% of pancreatic cancers. CEA is a cell-surface glycoprotein that is normally expressed during embryogenesis, with little to no expression in normal tissue, and is used as a serum tumor marker in patients with pancreatic cancer. The Anti-CEA Nanobody recognises this tumour marker. For this reason, it is often used in a labelled form to identify tumours.
Sequence and Features
Assembly Compatibility:
- 10INCOMPATIBLE WITH RFC[10]Illegal PstI site found at 244
- 12INCOMPATIBLE WITH RFC[12]Illegal PstI site found at 244
- 21COMPATIBLE WITH RFC[21]
- 23INCOMPATIBLE WITH RFC[23]Illegal PstI site found at 244
- 25INCOMPATIBLE WITH RFC[25]Illegal PstI site found at 244
- 1000COMPATIBLE WITH RFC[1000]
References
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138244/